 Therapy will continue for 12 weeks. Treatment will then be altered and the new treatment will be continued through Week 24. Interim Study Visits will be required at Weeks 2 and 4 Treatment Period 1 and at Weeks 14 and 16 Treatment Period 2. Subjects will be offered to be enrolled into a maintenance Protocol Study 23056 at Week 24. 